Insmed (INSM) Other Non Operating Income (2013 - 2026)
Insmed's (INSM) quarterly Other Non Operating Income came in at -$736000.0 in Q1 2026, down 657.58% year-on-year from $132000.0 in Q1 2025, and up 59.63% quarter-over-quarter from -$1.8 million in Q4 2025.
Insmed (INSM) Other Non Operating Income (2013 - 2026) Analysis & Trends
Insmed's Other Non Operating Income history runs 14 years deep, the most recent figure standing at -$736000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 657.58% year-over-year to -$736000.0 in Q1 2026; TTM through Mar 2026 was -$2.1 million, a 47.95% increase from a year earlier, with the FY2025 full-year figure at -$1.8 million, down 680.08% from the prior year.
- Other Non Operating Income improved to -$736000.0 in Q1 2026 per INSM's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.5 million in Q4 2023 and bottomed at -$3.9 million in Q3 2024.
- The 5-year median for Other Non Operating Income is $10500.0 (2023), against an average of -$198000.0.
- Across the five-year window, Other Non Operating Income soared 210.27% in 2023 and sank 1451.58% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $1.1 million in 2022, then surged by 210.27% to $3.5 million in 2023, then tumbled by 120.25% to -$710000.0 in 2024, then tumbled by 156.76% to -$1.8 million in 2025, then surged by 59.63% to -$736000.0 in 2026.
- Per Business Quant, the three latest INSM Other Non Operating Income figures stand at -$736000.0 (Q1 2026), -$1.8 million (Q4 2025), and $453000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -736,000.00 |
| Dec 31, 2025 | -1.82 Mn |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | -710,000.00 |
| Sep 30, 2024 | -3.85 Mn |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Sep 30, 2023 | 285,000.00 |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | -111,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -1.51 Mn |
| Dec 31, 2021 | 14.36 Mn |
| Jun 30, 2021 | -17.69 Mn |
| Mar 31, 2021 | -43,000.00 |
| Sep 30, 2020 | -4,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | 255,000.00 |